Developer of artificial intelligence-based diagnostic tests designed to support precision oncology and biomarker-driven medicine. Waiv is based in Paris, France. Its last reported valuation was $499 million in Mar 2026. It has raised $32.9 million.
Last reported valuation
$499.1M
Oct 2026
Priced at
—
Total raised
$32.9M
Last round
—
Team — not yet on record
No current team members for Waiv are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Waiv with a free account
·Watch Waiv: the Monday email on marks, rounds and moves
